MRP8/14 serum levels as a predictor of response to starting and stopping anti-TNF treatment in juvenile idiopathic arthritis

INTRODUCTION: Approximately 30 % of juvenile idiopathic arthritis (JIA) patients fail to respond to anti-TNF treatment. When clinical remission is induced, some patients relapse after treatment has been stopped. We tested the predictive value of MRP8/14 serum levels to identify responders to treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Anink, Janneke, Van Suijlekom-Smit, Lisette W. A., Otten, Marieke H., Prince, Femke H. M., van Rossum, Marion A. J., Dolman, Koert M., Hoppenreijs, Esther P. A. H., ten Cate, Rebecca, Ursu, Simona, Wedderburn, Lucy R., Horneff, Gerd, Frosch, Michael, Vogl, Thomas, Gohar, Faekah, Foell, Dirk, Roth, Johannes, Holzinger, Dirk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4528380/
https://www.ncbi.nlm.nih.gov/pubmed/26249667
http://dx.doi.org/10.1186/s13075-015-0723-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4528380/
https://www.ncbi.nlm.nih.gov/pubmed/26249667
http://dx.doi.org/10.1186/s13075-015-0723-1

Ejemplares similares